[Cloning, expression and identification of recombinant fusion protein GX1-rmhTNFalpha]

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 May;22(3):360-2.
[Article in Chinese]

Abstract

Aim: To construct prokaryotic vector GX1-rmhTNF containing neovascular-targeting peptide GX1 and human TNFalpha and produce the GX1-rmhTNF protein.

Methods: We have previously obtained a specific phage peptide CGNSNPKSC (GX1) binding to vasculature of human gastric cancer. The GX1-rmhTNFalpha vector was constructed by merging sequence of neovascular-targeting peptide GX1 with N-terminal of new recombined human TNFalpha (rmhTNFalpha) using gene engineering methods. The expression of the fusion protein GX1-rmhTNFalpha in E. coli was induced by temperature. The expression of GX1-rmhTNFalpha was detected by SDS-PAGE and Western blot.

Results: A novel protein with expected molecular mass about 18,000 was found after SDS-PAGE and gel staining. The expressed product showed a good binding ability to anti-TNFalpha monoclonal antibody.

Conclusion: The prokaryotic vector GX1-rmhTNF was constructed and the expression of GX1-rmhTNF protein was successfully induced, which was helpful for further purification of GX1-rmhTNF protein.

MeSH terms

  • Blotting, Western
  • Cloning, Molecular
  • Drug Delivery Systems
  • Escherichia coli / genetics
  • Gene Expression
  • Genetic Vectors
  • Humans
  • Molecular Sequence Data
  • Oligopeptides / chemistry
  • Oligopeptides / genetics
  • Oligopeptides / metabolism*
  • Peptides / genetics
  • Peptides / metabolism*
  • Peptides, Cyclic
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism*
  • Recombinant Fusion Proteins / therapeutic use
  • Temperature
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Oligopeptides
  • Peptides
  • Peptides, Cyclic
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • cyclo(cysteinyl-glycyl-aspargyl-seryl-aspargyl-prolyl-lysyl-seryl-cysteine)